NLS

Both Danes and Swedes like to emphasize, and often make fun of, the more or less significant differences between our cultures.

In the old days, the major pharmaceutical companies and successful life science companies were generally in the driving seat and could pick and choose from qualified candidates. Prestigious public hospitals and/or hospitals located in the major city centers were in a similar position. Today the balance of power has  shifted somewhat, and because of the […]

Boston’s Kendall Square, close to Massachusetts Institute of Technology (MIT), is known as “The most innovative square mile on the planet” and, apart from our preference for the metric system, there just might be something we could learn from the Americans. One of the recommendations is that public and private stakeholders, inspired by the success […]

Women’s health has been under-prioritized for a long time. It should be no surprise that women are approximately one half of the world’s population. Yet remarkably, only 1% of healthcare research and innovation is invested in specific female conditions outside oncology. At Medicon Valley Alliance we have decided to pick up the gauntlet and test the interest […]

In June 2023, the Swedish Presidency of the Council of the European Union called for reinforcing, accelerating, and maximizing the benefits of fair and open research data in Europe, within scientific communities and through research infrastructures, to increase the overall research and innovation performance in Europe and strengthen the outreach to and impact on industry […]

Life science innovation is dynamic by definition. This is the reason why any national life science strategy needs to be updated on a regular basis. When some challenges have been addressed, new challenges emerge, and priorities shift as circumstances change and new lessons are learned. In April the new Danish coalition government formally kicked-off the […]